A randomized double-blind pilot study comparing cetirizine with diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions.

被引：0
|
作者：
Bouchard, Philippe
Beaucage-Charron, Johannie
Gaudet, Laurence
Lamothe, Sarah
Pelletier, Cloe
Pepin, Anne-Sophie
Roy, Valerie
Charpentier, Frederic
Lordkipanidze, Marie
Projean, Denis
Picard, Matthieu
机构：
[1] Hop Maisonneuve Rosemont, Montreal, PQ, Canada
[2] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[3] Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e24080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24080
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A randomized double-blind feasibility study comparing cetirizine and diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions: the PREMED-F1 study
    Beaucage-Charron, Johannie
    Gaudet, Laurence
    Lamothe, Sarah
    Pelletier, Cloe
    Pepin, Anne-Sophie
    Roy, Valerie
    Charpentier, Frederic
    Lordkipanidze, Marie
    Projean, Denis
    Bouchard, Philippe
    Picard, Matthieu
    SUPPORTIVE CARE IN CANCER, 2022, 30 (04) : 3389 - 3399
  • [2] A randomized double-blind feasibility study comparing cetirizine and diphenhydramine in the prevention of paclitaxel-associated infusion-related reactions: the PREMED-F1 study
    Johannie Beaucage-Charron
    Laurence Gaudet
    Sarah Lamothe
    Cloé Pelletier
    Anne-Sophie Pépin
    Valérie Roy
    Frédéric Charpentier
    Marie Lordkipanidzé
    Denis Projean
    Philippe Bouchard
    Matthieu Picard
    Supportive Care in Cancer, 2022, 30 : 3389 - 3399
  • [3] Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)
    Smoot, Kyle
    Marginean, Horia
    Gervasi-Follmar, Tiffany
    Chen, Chiayi
    MEDICINA-LITHUANIA, 2024, 60 (04):
  • [4] Comparing the risk and severity of infusion-related reactions in patients premedicated with cetirizine versus diphenhydramine prior to ocrelizumab infusions (PRECEPT)
    Smoot, K.
    Marginean, H.
    Gervasi-Follmar, T.
    Chen, C.
    Cohan, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 403 - 403
  • [5] Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine:: A randomized, placebo-controlled, double-blind study
    Strasser, Florian
    Demmer, Ruth
    Boehme, Christel
    Schmitz, Shu-Fang Hsu
    Thuerlimann, Beat
    Cerny, Thomas
    Gillessen, Silke
    ONCOLOGIST, 2008, 13 (03): : 337 - 346
  • [6] A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome.
    Dayao, Zoneddy R.
    Brown-Glaberman, Ursa Abigail
    Pankratz, V. Shane
    Chen, Lu
    Lafky, Jacqueline M.
    Loprinzi, Charles L.
    Barton, Debra L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Effect of Melatonin on Paclitaxel-Associated Acute and Chronic Pain: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Talaee, Naeeme
    Ebrahimpour, Sholeh
    Sfandbod, Mohsen
    Majedi, Hossein
    Kohneloo, Aarefeh Jafarzadeh
    Gholami, Kheirollah
    Jahangard-Rafsanjani, Zahra
    PHARMACEUTICAL SCIENCES, 2022, 28 (04) : 579 - 588
  • [8] A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania
    Delbello, MP
    Kowatch, RA
    Adler, CM
    Stanford, KE
    Welge, JA
    Barzman, DH
    Nelson, E
    Strakowski, SM
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (03): : 305 - 313
  • [9] A prospective, randomized, double-blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions
    Kennedy, LeAnne D.
    Case, L. Douglas
    Hurd, David D.
    Cruz, Julia M.
    Pomper, Gregory J.
    TRANSFUSION, 2008, 48 (11) : 2285 - 2291
  • [10] Infusion-related reactions in the Phase III double-blind, placebo-controlled ORATORIO study of ocrelizumab in primary progressive multiple sclerosis (PPMS)
    Montalban, X.
    Arnold, D.
    Bar-or, A.
    de Seze, J.
    Giovannoni, G.
    Hemmer, B.
    Rammohan, K.
    Mairon, N.
    Chin, P.
    Fontoura, P.
    Garren, H.
    Masterman, D.
    Sauter, A.
    Wolinsky, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 410 - 410
12345